Integrated Filing — IndAS


General information about company

Scrip Code 540005
NSE Symbol LTIM
MSEI Symbol NOTLISTED
ISIN INE214T01019
Name of company LTIMINDTREE LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 23-Apr-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 07-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 23-Apr-2025   14:00:00
End date and time of board meeting 23-Apr-2025   16:10:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 97717000000 380081000000
Other income 2512000000 9897000000
Total income 100229000000 389978000000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0 0
(d) Employee benefit expense 64666000000 246226000000
(e) Finance costs 673000000 2789000000
(f) Depreciation, depletion and amortisation expense 2508000000 9915000000
(f) Other Expenses
1 Subcontracting expenses 6078000000 26312000000
2 Other Expenses 11011000000 42594000000
Total other expenses 17089000000 68906000000
Total expenses 84936000000 327836000000
3 Total profit before exceptional items and tax 15293000000 62142000000
4 Exceptional items 0 0
5 Total profit before tax 15293000000 62142000000
6 Tax expense
7 Current tax 3727000000 15784000000
8 Deferred tax 280000000 338000000
9 Total tax expenses 4007000000 16122000000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 11286000000 46020000000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 11286000000 46020000000
17 Other comprehensive income net of taxes 2850000000 -546000000
18 Total Comprehensive Income for the period 14136000000 45474000000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 11285000000 45987000000
Total profit or loss, attributable to non-controlling interests 1000000 1000000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 14132000000 45434000000
Total comprehensive income for the period attributable to owners of parent non-controlling interests 4000000 40000000
21 Details of equity share capital
Paid-up equity share capital 296000000 296000000
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 226819000000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 38.1 155.29
Diluted earnings (loss) per share from continuing operations 38.04 155
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 38.1 155.29
Diluted earnings (loss) per share from continuing and discontinued operations 38.04 155
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 39631000000
Capital work-in-progress 5818000000
Investment property 0
Goodwill 12036000000
Other intangible assets 1180000000
Intangible assets under development 996000000
Biological assets other than bearer plants 0
Investments accounted for using equity method 6000000
Non-current financial assets
Non-current investments 24700000000
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 4400000000
Total non-current financial assets 29100000000
Deferred tax assets (net) 2220000000
Other non-current assets 5934000000
Total non-current assets 96921000000
2 Current assets
Inventories 28000000
Current financial asset
Current investments 73740000000
Trade receivables, current 58676000000
Cash and cash equivalents 20623000000
Bank balance other than cash and cash equivalents 15259000000
Loans, current 0
Other current financial assets 20942000000
Total current financial assets 189240000000
Current tax assets (net) 77000000
Other current assets 20034000000
Total current assets 209379000000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 306300000000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 296000000
Other equity 226687000000
Total equity attributable to owners of parent 226983000000
Non controlling interest 132000000
Total equity 227115000000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 19010000000
Total non-current financial liabilities 19010000000
Provisions, non-current 197000000
Deferred tax liabilities (net) 319000000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 19526000000
Current liabilities
Current financial liabilities
Borrowings, current 23000000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 295000000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 15204000000
Total Trade payable 15499000000
Other current financial liabilities 16788000000
Total current financial liabilities 32310000000
Other current liabilities 16736000000
Provisions, current 9691000000
Current tax liabilities (Net) 922000000
Deferred government grants, Current 0
Total current liabilities 59659000000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 79185000000
Total equity and liabilites 306300000000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Unaudited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Banking, Financial Services & Insurance 36242000000 137318000000
2 Technology, Media & Communications 22952000000 93125000000
3 Manufacturing & Resources 19486000000 72137000000
4 Consumer Business 13705000000 54420000000
5 Healthcare, Life sciences & Public Services 5332000000 23081000000
Total Segment Revenue 97717000000 380081000000
Less: Inter segment revenue
Revenue from operations 97717000000 380081000000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Banking, Financial Services & Insurance 5889000000 21752000000
2 Technology, Media & Communications 4709000000 19694000000
3 Manufacturing & Resources 2628000000 10373000000
4 Consumer Business 2379000000 9768000000
5 Healthcare, Life sciences & Public Services 357000000 3362000000
Total Profit before tax 15962000000 64949000000
i. Finance cost 673000000 673000000
ii. Other Unallocable Expenditure net off Unallocable income -4000000 -4000000
Profit before tax 15293000000 62142000000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Banking, Financial Services & Insurance 0 0
2 Technology, Media & Communications 0 0
3 Manufacturing & Resources 0 0
4 Consumer Business 0 0
5 Healthcare, Life sciences & Public Services 0 0
Total Segment Asset 0 0
Un-allocable Assets 0 0
Net Segment Asset 0 0
4 Segment Liabilities
Segment Liabilities
1 Banking, Financial Services & Insurance 0 0
2 Technology, Media & Communications 0 0
3 Manufacturing & Resources 0 0
4 Consumer Business 0 0
5 Healthcare, Life sciences & Public Services 0 0
Total Segment Liabilities 0 0
Un-allocable Liabilities 0 0
Net Segment Liabilities 0 0
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Defined benefit plan actuarial gain/(loss) -97000000 21000000
Total Amount of items that will not be reclassified to profit and loss -97000000 21000000
2 Income tax relating to items that will not be reclassified to profit or loss -24000000 5000000
3 Amount of items that will be reclassified to profit and loss
1 Net changes in fair value of cash flow hedges 3626000000 -671000000
2 Foreign Currency Translation Reserve - During the year 209000000 -60000000
Total Amount of items that will be reclassified to profit and loss 3835000000 -731000000
4 Income tax relating to items that will be reclassified to profit or loss 912000000 -169000000
5 Total Other comprehensive income 2850000000 -546000000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 62142000000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 2789000000
Adjustments for decrease (increase) in inventories 2000000
Adjustments for decrease (increase) in trade receivables, current -4624000000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -3612000000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 3431000000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 9915000000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 0
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -418000000
Adjustments for dividend income 0
Adjustments for interest income 3421000000
Adjustments for share-based payments 588000000
Adjustments for fair value losses (gains) -4918000000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow -147000000
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 105000000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -310000000
Net cash flows from (used in) operations 61832000000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 16374000000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 45458000000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 269399000000
Other cash payments to acquire equity or debt instruments of other entities 280946000000
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 6000000
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 160000000
Purchase of property, plant and equipment 9496000000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 3582000000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -75000000
Net cash flows from (used in) investing activities -17382000000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 35000000
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 399000000
Payments of lease liabilities 3083000000
Dividends paid 19246000000
Interest paid 2706000000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -345000000
Net cash flows from (used in) financing activities -25744000000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 2332000000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 91000000
Net increase (decrease) in cash and cash equivalents 2423000000
Cash and cash equivalents cash flow statement at beginning of period 18200000000
Cash and cash equivalents cash flow statement at end of period 20623000000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Deloitte Haskins & Sells Chartered Accountants LLP Yes 31-Dec-2027


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date